PMC:7096775 / 4088-4882 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T29","span":{"begin":67,"end":75},"obj":"Disease"},{"id":"T30","span":{"begin":407,"end":415},"obj":"Disease"},{"id":"T31","span":{"begin":537,"end":549},"obj":"Disease"},{"id":"T32","span":{"begin":554,"end":562},"obj":"Disease"},{"id":"T33","span":{"begin":620,"end":628},"obj":"Disease"},{"id":"T34","span":{"begin":693,"end":730},"obj":"Disease"},{"id":"T35","span":{"begin":713,"end":730},"obj":"Disease"},{"id":"T36","span":{"begin":732,"end":736},"obj":"Disease"},{"id":"T37","span":{"begin":741,"end":754},"obj":"Disease"},{"id":"T39","span":{"begin":761,"end":769},"obj":"Disease"}],"attributes":[{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0002118"},{"id":"A38","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0005240"},{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Crude and adjusted values of mean and median age were lower in all COVID-19 case series compared with SPP (Table). The proportion of females differed between the case series, ranging from 32% in Wuhan to 59% in Zhejiang. The adjusted SPP showed a range from 39% to 42% in the proportions of females throughout the 5 years under consideration. The overall proportion of comorbidities was much smaller in the COVID-19 case series (range: 20–51%) than in German patients, where the proportion ranged from 70% to 77%, depending on the year. Hypertension and diabetes were the most important chronic comorbidities both among COVID-19 patients and among SPP. However, there were fewer patients with chronic obstructive pulmonary disease (COPD) or renal disease among COVID-19 patients than among SPP."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T15","span":{"begin":133,"end":140},"obj":"http://purl.obolibrary.org/obo/UBERON_0003100"},{"id":"T16","span":{"begin":245,"end":246},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T17","span":{"begin":291,"end":298},"obj":"http://purl.obolibrary.org/obo/UBERON_0003100"}],"text":"Crude and adjusted values of mean and median age were lower in all COVID-19 case series compared with SPP (Table). The proportion of females differed between the case series, ranging from 32% in Wuhan to 59% in Zhejiang. The adjusted SPP showed a range from 39% to 42% in the proportions of females throughout the 5 years under consideration. The overall proportion of comorbidities was much smaller in the COVID-19 case series (range: 20–51%) than in German patients, where the proportion ranged from 70% to 77%, depending on the year. Hypertension and diabetes were the most important chronic comorbidities both among COVID-19 patients and among SPP. However, there were fewer patients with chronic obstructive pulmonary disease (COPD) or renal disease among COVID-19 patients than among SPP."}

{"project":"LitCovid-sentences","denotations":[{"id":"T28","span":{"begin":0,"end":114},"obj":"Sentence"},{"id":"T29","span":{"begin":115,"end":220},"obj":"Sentence"},{"id":"T30","span":{"begin":221,"end":342},"obj":"Sentence"},{"id":"T31","span":{"begin":343,"end":435},"obj":"Sentence"},{"id":"T32","span":{"begin":436,"end":536},"obj":"Sentence"},{"id":"T33","span":{"begin":537,"end":652},"obj":"Sentence"},{"id":"T34","span":{"begin":653,"end":794},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Crude and adjusted values of mean and median age were lower in all COVID-19 case series compared with SPP (Table). The proportion of females differed between the case series, ranging from 32% in Wuhan to 59% in Zhejiang. The adjusted SPP showed a range from 39% to 42% in the proportions of females throughout the 5 years under consideration. The overall proportion of comorbidities was much smaller in the COVID-19 case series (range: 20–51%) than in German patients, where the proportion ranged from 70% to 77%, depending on the year. Hypertension and diabetes were the most important chronic comorbidities both among COVID-19 patients and among SPP. However, there were fewer patients with chronic obstructive pulmonary disease (COPD) or renal disease among COVID-19 patients than among SPP."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":537,"end":549},"obj":"Phenotype"},{"id":"T10","span":{"begin":693,"end":730},"obj":"Phenotype"},{"id":"T11","span":{"begin":732,"end":736},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0006510"}],"text":"Crude and adjusted values of mean and median age were lower in all COVID-19 case series compared with SPP (Table). The proportion of females differed between the case series, ranging from 32% in Wuhan to 59% in Zhejiang. The adjusted SPP showed a range from 39% to 42% in the proportions of females throughout the 5 years under consideration. The overall proportion of comorbidities was much smaller in the COVID-19 case series (range: 20–51%) than in German patients, where the proportion ranged from 70% to 77%, depending on the year. Hypertension and diabetes were the most important chronic comorbidities both among COVID-19 patients and among SPP. However, there were fewer patients with chronic obstructive pulmonary disease (COPD) or renal disease among COVID-19 patients than among SPP."}

{"project":"LitCovid-PubTator","denotations":[{"id":"81","span":{"begin":459,"end":467},"obj":"Species"},{"id":"82","span":{"begin":629,"end":637},"obj":"Species"},{"id":"83","span":{"begin":679,"end":687},"obj":"Species"},{"id":"84","span":{"begin":770,"end":778},"obj":"Species"},{"id":"85","span":{"begin":67,"end":75},"obj":"Disease"},{"id":"86","span":{"begin":407,"end":415},"obj":"Disease"},{"id":"87","span":{"begin":537,"end":549},"obj":"Disease"},{"id":"88","span":{"begin":554,"end":562},"obj":"Disease"},{"id":"89","span":{"begin":620,"end":628},"obj":"Disease"},{"id":"90","span":{"begin":693,"end":730},"obj":"Disease"},{"id":"91","span":{"begin":732,"end":736},"obj":"Disease"},{"id":"92","span":{"begin":741,"end":754},"obj":"Disease"},{"id":"93","span":{"begin":761,"end":769},"obj":"Disease"}],"attributes":[{"id":"A81","pred":"tao:has_database_id","subj":"81","obj":"Tax:9606"},{"id":"A82","pred":"tao:has_database_id","subj":"82","obj":"Tax:9606"},{"id":"A83","pred":"tao:has_database_id","subj":"83","obj":"Tax:9606"},{"id":"A84","pred":"tao:has_database_id","subj":"84","obj":"Tax:9606"},{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"MESH:C000657245"},{"id":"A86","pred":"tao:has_database_id","subj":"86","obj":"MESH:C000657245"},{"id":"A87","pred":"tao:has_database_id","subj":"87","obj":"MESH:D006973"},{"id":"A88","pred":"tao:has_database_id","subj":"88","obj":"MESH:D003920"},{"id":"A89","pred":"tao:has_database_id","subj":"89","obj":"MESH:C000657245"},{"id":"A90","pred":"tao:has_database_id","subj":"90","obj":"MESH:D029424"},{"id":"A91","pred":"tao:has_database_id","subj":"91","obj":"MESH:D029424"},{"id":"A92","pred":"tao:has_database_id","subj":"92","obj":"MESH:D007674"},{"id":"A93","pred":"tao:has_database_id","subj":"93","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Crude and adjusted values of mean and median age were lower in all COVID-19 case series compared with SPP (Table). The proportion of females differed between the case series, ranging from 32% in Wuhan to 59% in Zhejiang. The adjusted SPP showed a range from 39% to 42% in the proportions of females throughout the 5 years under consideration. The overall proportion of comorbidities was much smaller in the COVID-19 case series (range: 20–51%) than in German patients, where the proportion ranged from 70% to 77%, depending on the year. Hypertension and diabetes were the most important chronic comorbidities both among COVID-19 patients and among SPP. However, there were fewer patients with chronic obstructive pulmonary disease (COPD) or renal disease among COVID-19 patients than among SPP."}